DR
Therapeutic Areas
Strata Oncology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Immunotherapy Response Score (IRS) | Pan-solid tumors for anti-PD-1/PD-L1 monotherapy benefit | Commercial |
| Antibody-Drug Conjugate Treatment Response Score (ADC TRS) | Multiple cancers for ADC therapy benefit | Development/Validation |